Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
glaxosmithkline
3
×
indiana blog main
indiana top stories
life sciences
3
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
akcea therapeutics
clinical trials
gene therapy
ipo
loxo oncology
medical devices
medicare
nonalcoholic steatohepatitis
novartis
scott gottlieb
vaccine
What
bio
3
×
cancer
3
×
roundup
abbvie’s
ahead
allogene
appetite
biofourmis
black
bread
bucks
butter
buyout
cash
celebrate
chance
corner
crispr
day
days
diabetes
diamond’s
diversity
drugs
eli
forward
giant
grabbed
hasn’t
hold
holiday
hot
immunotherapy
investors
ipo
juno
labor
lilly's
looking
lost
Language
unset
Current search:
glaxosmithkline
×
bio
×
biotech
×
cancer
×
" life sciences "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More